Thrivent Financial for Lutherans
RCUS icon

Thrivent Financial for Lutherans’s Arcus Biosciences RCUS Stock Holding History

Thrivent Financial for Lutherans’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43M Buy
78,718
+8,843
+13% +$219K ﹤0.01% 1402
2026
Q1 		$1.51M Sell
69,875
-10,518
-13% -$227K ﹤0.01% 1640
2025
Q4 		$1.92M Buy
80,393
+30,484
+61% +$622K ﹤0.01% 1520
2025
Q3 		$679K Buy
49,909
+79
+0.2% +$821 ﹤0.01% 1968
2025
Q2 		$406K Buy
49,830
+401
+0.8% +$3.42K ﹤0.01% 2221
2025
Q1 		$388K Buy
49,429
+7,696
+18% +$89.2K ﹤0.01% 2159
2024
Q4 		$621K Sell
41,733
-627
-1% -$10.2K ﹤0.01% 2164
2024
Q3 		$648K Sell
42,360
-2,943
-6% -$46.4K ﹤0.01% 2138
2024
Q2 		$690K Sell
45,303
-1,592
-3% -$25.7K ﹤0.01% 2067
2024
Q1 		$885K Sell
46,895
-1,131
-2% -$19.6K ﹤0.01% 1961
2023
Q4 		$917K Sell
48,026
-1,046
-2% -$16.7K ﹤0.01% 1893
2023
Q3 		$881K Sell
49,072
-1,281
-3% -$25.7K ﹤0.01% 1830
2023
Q2 		$1.02M Sell
50,353
-1,312
-3% -$25K ﹤0.01% 1787
2023
Q1 		$942K Sell
51,665
-1,811
-3% -$34.6K ﹤0.01% 1823
2022
Q4 		$1.11M Sell
53,476
-231
-0.4% -$6.36K ﹤0.01% 1661
2022
Q3 		$1.41M Buy
53,707
+7,908
+17% +$209K ﹤0.01% 1458
2022
Q2 		$1.16M Buy
+45,799
New +$1.12M ﹤0.01% 1611

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Thrivent Financial for Lutherans's RCUS Position: Q2 2026 in Review

Thrivent Financial for Lutherans increased its Arcus Biosciences (RCUS) stake by 13% in Q2 2026, buying an estimated $219K and bringing the position to 78,718 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1402.

Thrivent Financial for Lutherans first reported a position in RCUS in Q2 2022 and has held it in 17 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Thrivent Financial for Lutherans held 78,718 shares of Arcus Biosciences worth $2.43M as of Q2 2026.
  • Thrivent Financial for Lutherans bought 8,843 Arcus Biosciences shares in Q2 2026, an estimated $219K.
  • Arcus Biosciences made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1402 holding.
  • Thrivent Financial for Lutherans first reported a position in Arcus Biosciences in Q2 2022 and has held it in 17 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.